DrugPatentWatch Database Preview
Drugs in Development Information for Molybdenum
Email this page to a colleague
» See Plans and PricingWhat is the development status for investigational drug Molybdenum?
Molybdenum is an investigational drug.
There have been 6 clinical trials for Molybdenum.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2016.
The most common disease conditions in clinical trials are Metal Metabolism, Inborn Errors, Preleukemia, and Myelodysplastic Syndromes. The leading clinical trial sponsors are Alexion Pharma GmbH, Canadian Institutes of Health Research (CIHR), and Meddoc AS.
There are twenty-six US patents protecting this investigational drug and one hundred and sixty-eight international patents.
Summary for Molybdenum
| US Patents | 26 |
| International Patents | 168 |
| US Patent Applications | 26 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2016-05-01) |
| Vendors | 28 |
Recent Clinical Trials for Molybdenum
| Title | Sponsor | Phase |
|---|---|---|
| Study of ALXN1101 in Neonates With Molybdenum Cofactor Deficiency (MOCD) Type A | Alexion Pharma GmbH | Phase 2/Phase 3 |
| A Blinded Study Evaluating the Accuracy and Safety of Cyclotron-produced 99mTc in Adult Patients | Canadian Institutes of Health Research (CIHR) | N/A |
| A Blinded Study Evaluating the Accuracy and Safety of Cyclotron-produced 99mTc in Adult Patients | Centre for Probe Development and Commercialization | N/A |
Clinical Trial Summary for Molybdenum
Top disease conditions for Molybdenum
Top clinical trial sponsors for Molybdenum
US Patents for Molybdenum
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Molybdenum | Start Trial | Overbased additives for lubricant oils containing a molybdenum complex, process for preparing them and compositions containing the said additives | Societe Nationale Elf Aquitaine (Courbevoie, FR) | Start Trial |
| Molybdenum | Start Trial | Hydrodealkylation of C9+ aromatic compounds | Phillips Petroleum Company (Bartlesville, OK) | Start Trial |
| Molybdenum | Start Trial | Hydrodealkylation of C.sub.9 + aromatic compounds | Phillips Petroleum Company (Bartlesville, OK) | Start Trial |
| Molybdenum | Start Trial | Catalysts made from transition metal compounds and 4, 5-diphosphinoacridine-ligands | Studiengesellschaft Kohle mbH (Mulheim an der Ruhr, DE) | Start Trial |
| Molybdenum | Start Trial | 2-phenyl benzimidazole derivatives as MCP-1 antagonists | Millennium Pharmaceuticals, Inc. (Cambridge, MA) | Start Trial |
| Molybdenum | Start Trial | Image recording material and planographic printing plate using same | Fuji Photo Film Co., Ltd. (Minami-Ashigara, JP) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Molybdenum
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Molybdenum | Germany | 69004163 | 2009-06-19 | Start Trial |
| Molybdenum | European Patent Office | 0404650 | 2009-06-19 | Start Trial |
| Molybdenum | Spain | 2060977 | 2009-06-19 | Start Trial |
| Molybdenum | France | 2648473 | 2009-06-19 | Start Trial |
| Molybdenum | Japan | 2883167 | 2009-06-19 | Start Trial |
| Molybdenum | Japan | H0335094 | 2009-06-19 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
